ESMO 2022 Conference Coverage
Playback speed
10 seconds
ESMO 2022 on the CheckMate 9LA Study Results: Clinical Outcomes in Patients With Tumor PD-L1<1% With 1L Nivo + Ipi + 2 Cycles of Chemo vs. Chemo Alone for mNSCLC
By
ESMO 2022 Conference Coverage
FEATURING
Tom John
By
ESMO 2022 Conference Coverage
FEATURING
Tom John
260 views
October 18, 2022
Comments 0
Login to view comments.
Click here to Login
Lung